Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1173064 | Desloratadine Related Compound F - (8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene) -5H-benzo[5,6]cyclohepta[1,2-b]pyridine) | 50 mg |
| USP-1184118 | Diaveridine - (5-(3,4-Dimethoxybenzyl)pyrimidine-2,4-diamine) | 25 mg |
| USP-1228541 | Dronedarone Related Compound A - (N-{2-Butyl-3-[4-(3-butylaminopropoxy)benzoyl]benzofuran-5-yl}methanesulfonamide, hydrochloride) | 25 mg |
| USP-1266868 | Ethyl Palmitate (Ethyl hexadecanoate) | 500 mg |
| USP-1370779 | Lufenuron | 200 mg |
| USP-1370724 | Lufenuron Related Compound B - (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide) | 15 mg |
| USP-1370735 | Lufenuron Related Compound C - (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide) | 15 mg |
| USP-1370780 | Lufenuron Related Compound G - (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate) | 15 mg |
| USP-1375047 | Maltotriose - 4-O-(4-O-alpha-D-glucopyranosyl)-alpha-D-glucopyranosyl-D-glucose | 500 mg |
| USP-1378023 | Medroxyprogesterone Acetate Related Compound B - (17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione) | 25 mg |
| USP-1444220 | Minoxidil Related Compound E - (6-(Piperidin-1-yl)pyrimidine-2,4-diamine) | 25 mg |
| USP-1457855 | Nebivolol Related Compound A - A mixture of (S)-1-[(R)-6-Fluorochroman-2-yl]-2-({(R)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol Hydrochloride, (R,1S,1'S)-2,2'-Azanediylbis{1-[(R)-6-fluorochroman-2-yl]ethanol} Hydrochloride and (S,1R,1'R)-2,2'-Azanediylbis{1-[(S)- 6-fluorochroman-2-yl]ethanol} Hydrochloride | 30 mg |
| USP-1457866 | Nebivolol Related Compound B - A mixture of (R)-1-[(R)-6-Fluorochroman-2-yl]-2-({(S)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride, (R)-1-[(R)-6-Fluorochroman-2-yl]-2-({(R)-2-[(R)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride and (S)-1-[(S)-6-Fluorochroman-2-yl]-2-({(S)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride | 30 mg |
| USP-1457877 | Nebivolol Related Compound C (COLD SHIPMENT REQUIRED) - ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman) | 100 mg |
| USP-1457899 | Nebivolol Related Compound E - (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride) | 30 mg |
| USP-1479053 | Orphenadrine Related Compound E - (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine) | 50 mg |
| USP-1479064 | Orphenadrine Related Compound F - (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate) | 50 mg |
| USP-1486015 | Oxymetazoline Related Compound A - (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride) | 15 mg |
| USP-1653026 | Theophylline Related Compound B - (3-Methyl-1H-purine-2,6-dione) | 25 mg |
| USP-1653037 | Theophylline Related Compound C - (N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide) | 25 mg |
| USP-1653048 | Theophylline Related Compound D - (N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate) | 30 mg |
| USP-1653060 | Theophylline Related Compound F - (7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione) | 25 mg |
| USP-1679020 | Triamcinolone Acetonide Related Compound B - (9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11beta,16alpha)-pregna-1,4,14-triene-3,20-dione) | 15 mg |
| USP-1679037 | Triamcinolone Acetonide Related Compound C - (9-Fluoro-11,21,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11beta,16alpha)-pregna-1,4-diene-3,20-dione) | 15 mg |
| USP-1028019 | Amitraz Related Compound A - (N-(2,4-Dimethylphenyl)formamide) | 40 mg |
| USP-1036110 | Aniline | 250 mg |
| USP-1098071 | Ceftiofur Hydrochloride | 100 mg |
| USP-1173279 | Desogestrel Related Compound D - (13-Ethyl-11-methylenegon-4-en-17-one) | 25 mg |
| USP-1269356 | Febantel | 200 mg |
| USP-1269367 | Febantel Related Compound A - (Methyl [[2-[(methoxyacetyl)amino]-4-(phenylthio)phenyl]carbamimidoyl]carbamate) | 15 mg |
| USP-1269378 | Febantel Related Compound B - (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole) | 15 mg |
| USP-1435014 | Methylprednisolone Related Compound A - (17,21-Dihydroxy-6alpha-methylpregna-1,4-diene-3,11,20-trione) | 25 mg |
| USP-1435036 | Methylprednisolone Related Compound C - (11beta-Hydroxy-6alpha-methylandrosta-1,4-diene-3,17-dione) | 25 mg |
| USP-1443431 | Miconazole Related Compound C - (2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine hydrochloride) | 50 mg |
| USP-1443464 | Miconazole Related Compound F - (1-{2-[(3,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole) | 50 mg |
| USP-1443497 | Miconazole Related Compound I - (1-{2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole mononitrate) | 50 mg |
| USP-1457833 | Nebivolol Hydrochloride | 150 mg |
| USP-1466572 | 4-Nitrobenzoic Acid | 50 mg |
| USP-1570029 | Promethazine Related Compound B - (N,N-Dimethyl-2-(10H-phenothiazin-10-yl)propan-1-amine hydrochloride) | 25 mg |
| USP-1592792 | Quetiapine Related Compound H - (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine 1-oxide) | 15 mg |
| USP-1600303 | Refined Bleached Shellac | 1 g |
| USP-1643736 | Teniposide | 200 mg |
| USP-1643747 | Teniposide Related Compound A - (4'-Demethylepipodophyllotoxin) | 10 mg |
| USP-1672053 | p-Toluidine - (COLD SHIPMENT REQUIRED) | 50 mg |
| USP-1706712 | Urea Related Compound A - (Dicarbonimidic diamide) | 15 mg |
| USP-1324319 | Hydroxocobalamin Chloride | 3 x 150 mg |
| USP-1086833 | Calcium Gluconate Monohydrate | 200 mg |
| USP-1535788 | Phosphatidylinositol (Soy) Sodium (10 mg) (COLD SHIPMENT REQUIRED) | 10 mg |
| USP-1028032 | Amitraz Related Compound C (40 mg) (N,N'-Bis(2,4-dimethylphenyl)formimidamide) (COLD SHIPMENT REQUIRED) | 40 mg |
| USP-1082592 | Butyl Anthranilate (1 mL) | 1 mL |
| USP-1133875 | Cidofovir Related Compound A (15 mg) (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine) | 15 mg |
| USP-1133886 | Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydrochloride) | 15 mg |
| USP-1369055 | Lithol Rubine BK (100 mg) (2-Naphthalenecarboxylic acid, 3-hydroxy-4-[(E)-2-(4-methyl-2-sulfophenyl)diazenyl]-, calcium salt (1:1)) | 100 mg |
| USP-1448672 | Moxifloxacin Related Compound G (15 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride) | 15 mg |
| USP-1488019 | Oxymorphone Related Compound A CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one N-oxide) | 25 mg |
| USP-1535959 | Phthalazine (20 mg) | 20 mg |
| USP-1623692 | Sulconazole Related Compound A (15 mg) (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate) | 15 mg |
| USP-1646010 | Testosterone Related Compound A CIII (20 mg) (Androst-4-ene-3,17-dione) | 20 mg |
| USP-1646031 | Testosterone Related Compound C (15 mg) (17alpha-Hydroxyandrost-4-en-3-one) | 15 mg |
| USP-1646097 | Testosterone Related Compound I (15 mg) (17beta-Hydroxyandrosta-4,6-dien-3-one) | 15 mg |
| USP-1000576 | Acamprosate Related Compound B (20 mg) - Calcium 3-formamidopropane-1-sulfonate | 20 mg |
| USP-1028028 | Amitraz Related Compound B (40 mg) -(N'-(2,4-Dimethylphenyl)-N-methylformimidamide (COLD SHIPMENT REQUIRED) | 40 mg |
| USP-1084292 | CD34+ Cell Enumeration System Suitability (1.24 x 10^4 CD34+ Cells) | each |
| USP-1098165 | Ceftiofur Sodium Trihydrate (100 mg) | 100 mg |
| USP-1102963 | Cetirizine Related Compound G (50 mg) - 2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethanol dihydrochloride | 50 mg |
| USP-1191554 | Didymin (30 mg) -((RS)-5-Hydroxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside | 30 mg |
| USP-1249803 | Esomeprazole Strontium (20 mg) - (-)-5-Methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole strontium salt tetrahydrate | 20 mg |
| USP-1304377 | Hesperidin (200 mg) - (RS)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside | 200 mg |
| USP-1349670 | Isonaringin (30 mg) - (RS)-5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside | 30 mg |
| USP-1354400 | Ixabepilone (100 mg) - (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione | 100 mg |
| USP-1354411 | Ixabepilone System Suitability Mixture (10 mg) | 10 mg |
| USP-1427027 | Methyldopa Related Compound B (10 mg) - (S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride | 10 mg |
| USP-1427038 | Methyldopa Related Compound C (20 mg) - (S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid hydrochloride monohydrate | 20 mg |
| USP-1430735 | Methylnaltrexone Bromide (100 mg) - (17RS)-17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium bromide | 100 mg |
| USP-1458042 | Neohesperidin (30 mg) - (S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside | 30 mg |
| USP-1500659 | Pemetrexed Disodium (100 mg) - Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate | 100 mg |
| USP-1611729 | Selamectin (350 mg) - (2aE,4E,5'S,6S,6'S,7S,8E,11R,13R,15S,17aR,20aR,20bS)-6'-Cyclohexyl-7-[(2,6-dideoxy-3-O-methyl-?-L-arabino-hexopyranosyl)oxy]-3',4',5',6,6',7,10,11,14,15,20a,20b-dodecahydro-20b-hydroxy-5',6,8,19-tetramethylspiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran]-17,20(17aH)-dione 20-oxime | 350 mg |
| USP-1667381 | Timolol Related Compound A (20 mg) - (R)-1-(tert-Butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-ol maleate | 20 mg |
| USP-1011889 | Advantame (200 mg) - N-[N-[3-(3-Hydroxy-4-methoxyphenyl)propyl]-alpha-L-aspartyl]-Lphenylalanine 1-methyl ester monohydrate | 200 mg |
| USP-1614716 | Anhydrous Sodium Succinate (250 mg) | 250 mg |
| USP-1133853 | Cidofovir (100 mg) - (1-[(S)-3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine dihydrate) | 100 mg |
| USP-1133864 | Cidofovir Enantiomer (15 mg) - (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate) | 15 mg |
| USP-1228552 | Dronedarone Related Compound B (20 mg) - ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride) | 20 mg |
| USP-1228563 | Dronedarone Related Compound C (20 mg) - ((5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) | 20 mg |
| USP-1228574 | Dronedarone Related Compound D (20 mg) - ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone) | 20 mg |
| USP-1010081 | N-Acetyl-L-Leucine (100 mg) - (Acetyl-L-leucine) | 100 mg |
| USP-1546194 | Polydatin (20 mg) - (3-Hydroxy-5-[(E)-2-(4-hydroxyphenyl)vinyl]phenyl Beta-D-glucopyranoside) | 20 mg |
| USP-1615311 | Solifenacin Identification Mixture A (15 mg) | 15 mg |
| USP-1615322 | Solifenacin Identification Mixture B (20 mg) | 20 mg |
| USP-1615300 | Solifenacin Succinate (100 mg) - ((R)-Quinuclidin-3-yl (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate succinate salt (1:1)) | 100 mg |
| USP-1619051 | Spironolactone Epimer Mixture (30 mg) - (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture) | 30 mg |
| USP-1619039 | Spironolactone Related Compound C (30 mg) - ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione) | 30 mg |
| USP-1619040 | Spironolactone Related Compound D (30 mg) - ((2'R)-7alpha-(Acetyldisulfanyl)-3',4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione) | 30 mg |
| USP-1619094 | Spironolactone Related Compound I (30 mg) - (S-[17alpha-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7alpha-yl]ethanethioate) | 30 mg |
| USP-1076419 | Brimonidine Related Compound A - (5-Bromoquinoxalin-6-amine) | 50 mg |
| USP-1076421 | Brimonidine Related Compound B - (1-(5-Bromoquinoxalin-6-yl)thiourea) | 50 mg |
| USP-1096586 | Carglumic Acid | 200 mg |
| USP-1096564 | D-Carglumic Acid - (N-Carbamoyl-D-glutamic acid) | 30 mg |
| USP-1096510 | Carglumic Acid Related Compound A - ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid) | 30 mg |
| USP-1106078 | Chlorambucil System Suitability Mixture - (A mixture containing 4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric acid and a small amount of 4-[m-[Bis(2-chloroethyl)amino]phenyl]butyric acid) | 25 mg |